Simplex Trading
HZNP

Simplex Trading’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Simplex Trading’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-265,300
Closed -$973K – 10303
2023
Q3 		$973K Buy
265,300
+167,600
+172% +$18M ﹤0.01% 2688
2023
Q2 		$10M Buy
97,700
+81,600
+507% +$8.61M 0.01% 889
2023
Q1 		$1.76M Sell
16,100
-128,500
-89% -$14.2M ﹤0.01% 2057
2022
Q4 		$16.5M Buy
144,600
+40,200
+39% +$3.34M 0.02% 632
2022
Q3 		$6.46M Buy
104,400
+73,500
+238% +$5.14M 0.01% 1036
2022
Q2 		$2.46M Sell
30,900
-6,000
-16% -$568K ﹤0.01% 1673
2022
Q1 		$3.88M Buy
36,900
+15,300
+71% +$1.49M ﹤0.01% 1467
2021
Q4 		$2.33M Sell
21,600
-4,800
-18% -$524K ﹤0.01% 1887
2021
Q3 		$2.55M Sell
26,400
-4,100
-13% -$426K ﹤0.01% 1855
2021
Q2 		$2.86M Buy
+30,500
New +$2.81M ﹤0.01% 1733
2021
Q1 		– Sell
-1,417
Closed -$10.4M – 10630
2020
Q4 		$10.4M Buy
1,417
+996
+237% +$74K 0.01% 573
2020
Q3 		$3.27M Sell
421
-213
-34% -$14.7K ﹤0.01% 1146
2020
Q2 		$3.52M Buy
634
+466
+277% +$19.9K 0.01% 1077
2020
Q1 		$497K Sell
168
-485
-74% -$16.4K ﹤0.01% 2594
2019
Q4 		$2.36M Buy
653
+463
+244% +$14.2K 0.01% 1332
2019
Q3 		$517K Sell
190
-18
-9% -$465 ﹤0.01% 2586
2019
Q2 		$500K Sell
208
-313
-60% -$7.94K ﹤0.01% 2562
2019
Q1 		$1.38M Buy
521
+300
+136% +$7.11K ﹤0.01% 1706
2018
Q4 		$431K Sell
221
-82
-27% -$1.61K ﹤0.01% 2363
2018
Q3 		$593K Buy
303
+153
+102% +$2.91K ﹤0.01% 2449
2018
Q2 		$248K Sell
150
-16
-10% -$244 ﹤0.01% 3237
2018
Q1 		$21K Sell
166
-355
-68% -$5.24K ﹤0.01% 3330
2017
Q4 		$54K Buy
521
+113
+28% +$1.59K ﹤0.01% 2383
2017
Q3 		$20K Buy
408
+11
+3% +$140 ﹤0.01% 3183
2017
Q2 		$22K Sell
397
-1,222
-75% -$15.2K ﹤0.01% 3236
2017
Q1 		$109K Sell
1,619
-3,131
-66% -$50.7K ﹤0.01% 1669
2016
Q4 		$182K Buy
4,750
+4,377
+1,173% +$79.4K 0.01% 1115
2016
Q3 		$122K Sell
373
-151
-29% -$2.95K 0.01% 1384
2016
Q2 		$48K Buy
524
+134
+34% +$2.17K ﹤0.01% 2111
2016
Q1 		$83K Buy
390
+68
+21% +$1.19K 0.01% 1517
2015
Q4 		$152K Sell
322
-807
-71% -$15.7K 0.01% 1062
2015
Q3 		$120K Buy
1,129
+1,025
+986% +$32.4K 0.01% 1281
2015
Q2 		$154K Sell
104
-286
-73% -$8.73K 0.01% 942
2015
Q1 		$592K Buy
+390
New +$7.15K 0.07% 268

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Simplex Trading's HZNP Position: Q4 2023 in Review

Simplex Trading sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 53,301 shares — an estimated $6.17M sold.

Simplex Trading first reported a position in HZNP in Q1 2015 and held it in 25 quarters. The position peaked at $7.71M in Q2 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Simplex Trading reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Simplex Trading sold 53,301 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $6.17M.
  • Simplex Trading first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2015 and held it in 25 quarters.
  • Simplex Trading's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $7.71M in Q2 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Simplex Trading's 13F filing for Q4 2023, filed 2 Feb 2024.